scholarly journals Regulation of Exosomes in the Pathogenesis of Breast Cancer

2021 ◽  
Author(s):  
Congjian Shi ◽  
Hongqin Yang ◽  
Zhengchao Wang ◽  
Zhenghong Zhang
Keyword(s):  
Breast Cancer ◽  
Lipid Bilayers ◽  
Cell Types ◽  
Cancer Diagnostics ◽  
Major Health Problem ◽  
Major Health ◽  
Diagnostic Strategies ◽  
Therapeutic Tools ◽  
Common Malignancy

Extracellular vesicles (EVs) are a heterogeneous group of endogenous nanoscale vesicles that are secreted by various cell types. Based on their biogenesis and size distribution, EVs can be broadly classified as exosomes and microvesicles. Exosomes are enveloped by lipid bilayers with a size of 30–150 nm in diameter, which contain diverse biomolecules, including lipids, proteins and nucleic acids. Exosomes transport their bioactive cargoes from original cells to recipient cells, thus play crucial roles in mediating intercellular communication. Breast cancer is the most common malignancy among women and remains a major health problem worldwide, diagnostic strategies and therapies aimed at breast cancer are still limited. Growing evidence shows that exosomes are involved in the pathogenesis of breast cancer, including tumorigenesis, invasion and metastasis. Here, we provide a straightforward overview of exosomes and highlight the role of exosomes in the pathogenesis of breast cancer, moreover, we discuss the potential application of exosomes as biomarkers and therapeutic tools in breast cancer diagnostics and therapeutics.

scholarly journals THE ROLE OF MICRORNA-200C IN CHEMORESISTANT BREAST CANCER

2020 ◽  
Vol 4 (2) ◽  
pp. 74
Author(s):  
Agung Bagus Sista Satyarsa ◽  
IGP Supadmanaba ◽  
PAT Adiputra
Keyword(s):  
Breast Cancer ◽  
Breast Cancer Cells ◽  
Target Cells ◽  
Major Health Problem ◽  
Major Health ◽  
Apoptosis Inducer ◽  
New Treatment ◽  
The One ◽  
Mesenchymal Epithelial Transition

Breast cancer is a non-communicable diseases and also major health problem in the world. Based on data from WHO in 2012, the incidence of breast cancer reported as 1.67 million cases. One cause of highest morbidity and mortality in breast cancer is chemoresistancy. Many pathways could cause chemoresistant in breast cancer. The one of pathways are from genetic such as miR-200c. Base on the other study, mir-200c act an apoptosis inducer and inhibit metastasis in chemoresistant breast cancer cells. The mir-200c act the role in specific target cells in chemoresistant breast cancer. Meanwhile, the expression of miR-200c induces Mesenchymal Epithelial Transition (MET) by inhibits ZEB 1 or 2 and TGF-β2 as anti-metastases in chemoresistant breast cancer. miR-200c has a promising potential as a new treatment for chemoresistant breast cancer, because of its potent pro-apoptotic and anti-metastatic properties.

scholarly journals The Evolving Role of Ferroptosis in Breast Cancer: Translational Implications Present and Future

Cancers ◽  
2021 ◽  
Vol 13 (18) ◽  
pp. 4576
Author(s):  
Hung-Yu Lin ◽  
Hui-Wen Ho ◽  
Yen-Hsiang Chang ◽  
Chun-Jui Wei ◽  
Pei-Yi Chu
Keyword(s):  
Breast Cancer ◽  
Cell Death ◽  
Regulatory Networks ◽  
Molecular Mechanisms ◽  
Drug Resistant ◽  
Therapeutic Targeting ◽  
The Past ◽  
Regulated Cell Death ◽  
Common Malignancy

Breast cancer (BC) is the most common malignancy among women worldwide. The discovery of regulated cell death processes has enabled advances in the treatment of BC. In the past decade, ferroptosis, a new form of iron-dependent regulated cell death caused by excessive lipid peroxidation has been implicated in the development and therapeutic responses of BC. Intriguingly, the induction of ferroptosis acts to suppress conventional therapy-resistant cells, and to potentiate the effects of immunotherapy. As such, pharmacological or genetic modulation targeting ferroptosis holds great potential for the treatment of drug-resistant cancers. In this review, we present a critical analysis of the current understanding of the molecular mechanisms and regulatory networks involved in ferroptosis, the potential physiological functions of ferroptosis in tumor suppression, its potential in therapeutic targeting, and explore recent advances in the development of therapeutic strategies for BC.

scholarly journals “CLUPS”: A New Culture Medium for the Axenic Growth ofEntamoeba histolytica

2018 ◽  
Vol 2018 ◽  
pp. 1-6
Author(s):  
F. Gonzalez-Salazar ◽  
I. Meester ◽  
F. J. Guzmán De La Garza ◽  
L. H. De La Garza-Salinas ◽  
A. Sampayo-Reyes ◽  
...  
Keyword(s):  
Culture Medium ◽  
Culture Media ◽  
Low Cost ◽  
The Novel ◽  
Phospholipase Activity ◽  
Major Health Problem ◽  
Beef Liver ◽  
Major Health ◽  
Liver Abscesses ◽  
Therapeutic Tools

Amebiasis remains a major health problem in Mexico. Therefore, the search for better culture media and low-cost diagnostic and therapeutic tools is fundamental. We present a new culture medium forEntamoeba histolyticawhich allows the microbe to preserve its virulence factors and ability to induce hepatic abscesses in animal models. The novel CLUPS medium is an improved version of the PEHPS medium, previously designed in our laboratory. The main difference is the substitution of raw beef liver in PEHPS by raw beef lung in the CLUPS medium. To compare the performance of three-culture media (traditional TYI-S-33, PEHPS, and CLUPS),E. histolyticatrophozoites were cultured in quintuplicate, followed by the evaluation of phospholipase activity and the induction of liver abscesses in golden hamsters.E. histolyticatrophozoites grew significantly better in CLUPS medium than in TYI-S-33. Likewise, CLUPS-cultured trophozoites produced significantly more phospholipases than TYI-S-33-cultured trophozoites. Finally, trophozoites grown in any of the three tested media had similar potential to induce liver abscesses.

A Computer-Assisted Diagnostic (CAD) of Screening Mammography to Detect Breast Cancer Without a Surgical Biopsy

2019 ◽  
Vol 11 (4) ◽  
pp. 31-49 ◽  
Author(s):  
Hadj Ahmed Bouarara
Keyword(s):  
Breast Cancer ◽  
Screening Mammography ◽  
Computer Assisted ◽  
Surgical Biopsy ◽  
Major Health Problem ◽  
Major Health ◽  
Cad System ◽  
Digital Database ◽  
The Social ◽  
N Gram

Breast cancer has become a major health problem in the world over the past 50 years and its incidence has increased in recent years. It accounts for 33% of all cancer cases, and 60% of new cases of breast cancer occur in women aged 50 to 74 years. In this work we have proposed a computer-assisted diagnostic (CAD) system that can predict whether a woman has cancer or not by analyzing her mammogram automatically without passing through a biopsy stage. The screening mammogram will be vectorized using the n-gram pixel representation. After the vectors obtained will be classified into one of the classes—with cancer or without cancer—using the social elephant algorithm. The experimentation using the digital database for screening mammography (DDSM) and validation measures—f-measure entropy recall, accuracy, specificity, RCT, ROC, AUC—show clearly the effectiveness and the superiority of our proposed bioinspired technique compared to others techniques existed in the literature such as naïve bayes, Knearest neighbours, and decision tree c4.5. The goal is to help radiologists with early detection to reduce the mortality rate among women with breast cancer.

scholarly journals Chemokines—What Is Their Role in Colorectal Cancer?

2020 ◽  
Vol 27 (1) ◽  
pp. 107327482090338 ◽  
Author(s):  
Sara Pączek ◽  
Marta Łukaszewicz-Zając ◽  
Barbara Mroczko
Keyword(s):  
Colorectal Cancer ◽  
Current Knowledge ◽  
Early Stage ◽  
Distant Metastases ◽  
Cell Types ◽  
Diagnosis And Prognosis ◽  
Novel Biomarkers ◽  
Specific Receptors ◽  
Common Malignancy

Colorectal cancer (CRC) is one of the leading causes of cancer-related death. It is the second most frequently diagnosed malignancy in Europe and third worldwide. Colorectal malignancies diagnosed at an early stage offer a promising survival rate. However, advanced tumors often present distant metastases even after the complete resection of a primary tumor. Therefore, novel biomarkers of CRC are sorely needed in the diagnosis and prognosis of this common malignancy. A family of chemokines are composed of small, secreted proteins. They are best known for their ability to stimulate the migration of several cell types. Some investigations have indicated that chemokines are involved in cancer development, including CRC. This article presents current knowledge regarding chemokines and their specific receptors in CRC progression. Moreover, the prime aim of this review is to summarize the potential role of these proteins as biomarkers in the diagnosis and prognosis of CRC.

scholarly journals Immunomodulatory Properties of HLA-G in Infectious Diseases

2014 ◽  
Vol 2014 ◽  
pp. 1-14 ◽  
Author(s):  
Laurence Amiot ◽  
Nicolas Vu ◽  
Michel Samson
Keyword(s):  
Infectious Diseases ◽  
Complex Molecule ◽  
Major Histocompatibility Complex Molecule ◽  
Cell Types ◽  
Inhibitory Effect ◽  
New Therapeutic Approaches ◽  
Extravillous Cytotrophoblasts ◽  
Cellular Source ◽  
Therapeutic Tools

HLA-G is a nonclassical major histocompatibility complex molecule first described at the maternal-fetal interface, on extravillous cytotrophoblasts. Its expression is restricted to some tissues in normal conditions but increases strongly in pathological conditions. The expression of this molecule has been studied in detail in cancers and is now also beginning to be described in infectious diseases. The relevance of studies on HLA-G expression lies in the well known inhibitory effect of this molecule on all cell types involved in innate and adaptive immunity, favoring escape from immune control. In this review, we summarize the features of HLA-G expression by type of infections (i.e, bacterial, viral, or parasitic) detailing the state of knowledge for each pathogenic agent. The polymorphism, the interference of viral proteins with HLA-G intracellular trafficking, and various cytokines have been described to modulate HLA-G expression during infections. We also discuss the cellular source of HLA-G, according to the type of infection and the potential role of HLA-G. New therapeutic approaches based on synthetic HLA-G-derived proteins or antibodies are emerging in mouse models of cancer or transplantation, and these new therapeutic tools may eventually prove useful for the treatment of infectious diseases.

scholarly journals Potency of Combination of Fucoidan Microsphere and MiRNA-200b as Therapy in Chemoresistant Breast Cancer

2020 ◽  
Vol 2 (5) ◽  
Author(s):  
Sinta Wiranata ◽  
Made VW Yani ◽  
Agung Bagus S Satyarsa ◽  
I Ketut R Ardiana ◽  
Putu AT Adiputra
Keyword(s):  
Breast Cancer ◽  
Breast Cancer Incidence ◽  
Migration And Invasion ◽  
Intrinsic Pathway ◽  
Extrinsic Pathway ◽  
Major Health Problem ◽  
Major Health ◽  
Mortality And Morbidity ◽  
Histone 3 ◽  
Apoptotic Signal

Breast cancer still become a major health problem in Indonesia and worldwide until today. Based on WHO 2012, breast cancer incidence is reported as 1.67 million cases with 90% of mortality rate in the metastasis stage. Chemoresistant is one cause of this increased mortality and morbidity. Nowadays, there are many treatment choices for cancer, but 90% incident of chemoresistant breast cancer occur even with prior chemotherapy. This review aimed to describe the potential of microsphere combinations fucoidan and miRNA-200b as a treatment for chemoresistant in breast cancer. Literature review were derived from scientific journals using www.pubmed.com and scholar.google.com database with “chemoresistant breast cancer, Fucoidan, microRNA-200b” as keyword. Fucoidan can induce apoptosis through the extrinsic pathway involving apoptotic receptor, or intrinsic pathway involving changes in mitochondrial membrane potential (MMP) to release cytochrome C and activating the apoptotic signal. Meanwhile, miRNA-200b expression, will decrease Sp1 expression and decrease histone-3 acetylation level in a miRNA-200b promoter, resulting in decreased cancer cell migration and invasion. However, no studies have evaluated this combination clinically. So, further studies are needed to confirm the potential of microsphere combination fucoidan and miRNA-200b in chemoresistant breast cancer.   Keywords: chemoresistant breast cancer; Fucoidan; miRNA-200b.

scholarly journals Precision Preventive Medicine of Relapse in Smoking Cessation: Can MRI Inform the Search of Intermediate Phenotypes?

Biology ◽  
2021 ◽  
Vol 11 (1) ◽  
pp. 35
Author(s):  
Yolaine Rabat ◽  
Sandra Chanraud ◽  
Majd Abdallah ◽  
Igor Sibon ◽  
Sylvie Berthoz
Keyword(s):  
Smoking Cessation ◽  
Meta Analysis ◽  
Major Health Problem ◽  
Major Health ◽  
Smoking Cessation Treatment ◽  
Intermediate Phenotypes ◽  
Prevention Therapy ◽  
Cessation Treatment ◽  
Magnetic Resonance Imaging Mri

Chronic tobacco smoking remains a major health problem worldwide. Numerous smokers wish to quit but most fail, even if they are helped. The possibility of identifying neuro-biomarkers in smokers at high risk of relapse could be of incredible progress toward personalized prevention therapy. Our aim is to provide a scoping review of this research topic in the field of Magnetic Resonance Imaging (MRI) and to review the studies that investigated if MRI defined markers predicted smoking cessation treatment outcome (abstainers versus relapsers). Based on the available literature, a meta-analysis could not be conducted. We thus provide an overview of the results obtained and take stock of methodological issues that will need to be addressed to pave the way toward precision medicine. Based on the most consistent findings, we discuss the pivotal role of the insula in light of the most recent neurocognitive models of addiction.

scholarly journals Role of Immune Cell-Specific Hypermethylation Signatures in Classification and Risk Stratification of Breast Cancer

2021 ◽  
Vol 8 ◽  
Author(s):  
Yong Chen ◽  
Fada Xia ◽  
Bo Jiang ◽  
Wenlong Wang ◽  
Xinying Li
Keyword(s):  
Breast Cancer ◽  
Risk Stratification ◽  
Immune Cells ◽  
Prediction Accuracy ◽  
Prognostic Value ◽  
Clinical Characteristics ◽  
Immune Cell ◽  
Cell Types ◽  
Clinical Model

Background: Epigenetic regulation, including DNA methylation, plays a major role in shaping the identity and function of immune cells. Innate and adaptive immune cells recruited into tumor tissues contribute to the formation of the tumor immune microenvironment (TIME), which is closely involved in tumor progression in breast cancer (BC). However, the specific methylation signatures of immune cells have not been thoroughly investigated yet. Additionally, it remains unknown whether immune cells-specific methylation signatures can identify subgroups and stratify the prognosis of BC patients.Methods: DNA methylation profiles of six immune cell types from eight datasets downloaded from the Gene Expression Omnibus were collected to identify immune cell-specific hypermethylation signatures (IC-SHMSs). Univariate and multivariate cox regression analyses were performed using BC data obtained from The Cancer Genome Atlas to identify the prognostic value of these IC-SHMSs. An unsupervised clustering analysis of the IC-SHMSs with prognostic value was performed to categorize BC patients into subgroups. Multiple Cox proportional hazard models were constructed to explore the role of IC-SHMSs and their relationship to clinical characteristics in the risk stratification of BC patients. Integrated discrimination improvement (IDI) was performed to determine whether the improvement of IC-SHMSs on clinical characteristics in risk stratification was statistically significant.Results: A total of 655 IC-SHMSs of six immune cell types were identified. Thirty of them had prognostic value, and 10 showed independent prognostic value. Four subgroups of BC patients, which showed significant heterogeneity in terms of survival prognosis and immune landscape, were identified. The model incorporating nine IC-SHMSs showed similar survival prediction accuracy as the clinical model incorporating age and TNM stage [3-year area under the curve (AUC): 0.793 vs. 0.785; 5-year AUC: 0.735 vs. 0.761]. Adding the IC-SHMSs to the clinical model significantly improved its prediction accuracy in risk stratification (3-year AUC: 0.897; 5-year AUC: 0.856). The results of IDI validated the statistical significance of the improvement (p < 0.05).Conclusions: Our study suggests that IC-SHMSs may serve as signatures of classification and risk stratification in BC. Our findings provide new insights into epigenetic signatures, which may help improve subgroup identification, risk stratification, and treatment management.

Breast Cancer Classification Using Nanochannel Arrays

2012 ◽  
Vol 1468 ◽  
Author(s):  
Kelly Flanagan ◽  
Krishna Vattipalli ◽  
Anjan Panneer Selvam ◽  
Shalini Prasad
Keyword(s):  
Breast Cancer ◽  
Electrochemical Impedance ◽  
Cellular Level ◽  
Cancer Diagnostics ◽  
Non Invasive ◽  
Cell Lysate ◽  
Disease Initiation ◽  
Nanochannel Arrays

ABSTRACTThe ability to design a diagnostics platform that can achieve cellular level as well as molecular level classification of targeted biomarkers may be critical toward understanding the fundamental basis of disease initiation and proliferation in breast cancer. In this context, we have looked at breast cancer diagnostics and present the design of a biomedical microdevice for evaluating and classifying cellular samples based on their risk towards metastasis. Primary breast cancer tumors have been shown to contain heterogeneous populations of neoplastic cells. Recent studies have demonstrated that subpopulations of these cells can cooperate in the initiation of collective invasion and metastasis. The role of the sensor we present is to identify the type of cells as non-invasive/”follower” cells that do not result in metastasis or invasive “leader” cells that are thought to be responsible for metastasis, from breast cancer cell lysate samples, thus enabling more selective classification of samples, with the eventual goal of early diagnosis. The device is an electrical immunoassay that incorporates the PDGF- receptor to screen the cell lysate samples for the PGDF binding protein that is preferentially expressed in the invasive, “leader” cells. The sensor comprises of alumina nanochannel arrays integrated on to a microelectronic platform operating on the principle of electrochemical impedance spectroscopy to quantify the PGDF protein from the cell lysates.

Sign in / Sign up

Export Citation Format

Share Document